glp-1 agonist dpp 4 inhibitor Inhibition of DPP-4. Food consumption boosts the release of and Comparison of GLP-1 receptor agonists

For the side effect models, we focused on the two phenotypes for which GWAS SNPs were identified (Supplementary Table 21)

This reduces the amount of glucose that enters the blood, especially after eating

Lv M, Xue G, Cheng H, Meng P, Lian X, Holscher C, et al

While the results from studies using native OXM in rodents and humans were promising, the short half-life in vivo and the large amount of peptide required to produce an effect made it a poor choice as a treatment in humans

Retrieved 17 April 2026

however, the most commonly used definition in our included studies was components of MI, stroke, and CV death or all-cause mortality